Skip to Main Content

Paper Details

A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
Cancer
10
2020
AKT, Cancer, FAK, HNSCC, HPV, HPV-negative, HPV-negative HNSCC, HPV-negative HNSCC cells, Head and neck squamous cell carcinoma, LOXL2, LOXL2 splice variant, LOXL2 splice variant gain and loss of expression cells, LOXL2 splice variants, LOXL2 variant, cancers, dominant LOXL2 variant, gene, human, human papillomavirus, human papillomavirus-negative head and neck squamous cell carcinoma, patients, reverse transcriptase, tumor
Author NameAffiliation
Chao LiuMoores Cancer Center, University of California at San Diego
Chao LiuXiangya Hospital, Central South University
Theresa GuoJohns Hopkins Medical Institutions
Theresa GuoJohns Hopkins Medical Institutions
Akihiro SakaiMoores Cancer Center, University of California at San Diego
Shuling RenMoores Cancer Center, University of California at San Diego
Shuling RenXiangya Hospital, Central South University
Takahito FukusumiMoores Cancer Center, University of California at San Diego
Mizuo AndoMoores Cancer Center, University of California at San Diego
Sayed SadatMoores Cancer Center, University of California at San Diego
Yuki SaitoMoores Cancer Center, University of California at San Diego
Joseph A CalifanoMoores Cancer Center, University of California at San Diego
Joseph A CalifanoUniversity of California at San Diego
  • 1 - 13

Datasets

Release 1.2